NEW YORK ( TheStreet) -- Syneron Medical (Nasdaq: ELOS) hit a new 52-week high Thursday as it traded at $14.56 compared with its previous 52-Week high of $14.45. Syneron Medical is changing hands at $14.49 with 137,757 shares traded as of 9:56 a.m. ET. Average volume has been 203,800 shares over the past 30 days. Syneron Medical has a market cap of $496.1 million and is part of the health care sector and health services industry. Shares are up 38.4% year to date as of the close of trading on Wednesday. Syneron Medical Ltd., together with its subsidiaries, engages in the research, development, marketing, and sale of aesthetic medical products worldwide. TheStreet Ratings rates Syneron Medical as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full Syneron Medical Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.
More from Markets
No Energy? No Problem, This Market Will Find a Way to Go Higher
Earnings season continues to be upbeat and there are no signs of the economic weakness the bears were looking for.
Dow Ends Up Triple Digits; Stocks Surge on U.S.-China Trade Talk Hopes
Stocks surge late Tuesday as investors are buoyed by reports of renewed trade talks with China and strong earnings reports.
Jim Cramer: The First Place to Go When Researching a Company
Jim Cramer's got some advice for investors looking to do their homework on a company.
Replay: Jim Cramer's Thoughts on Earnings, Apple, and Snap
Jim Cramer has some advice for investors listening to their market gurus, and he weighs in on how markets are doing with the slew of earnings that we've received and what he thinks of the reported offer Apple made Intel for its smartphone modem chip business.